ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 64 filers reported holding ENZON PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $764,000 | +2.7% | 707,964 | -1.0% | 0.00% | 0.0% |
| Q2 2014 | $744,000 | +2.6% | 715,405 | +1.6% | 0.00% | 0.0% |
| Q1 2014 | $725,000 | -11.9% | 704,078 | -0.8% | 0.00% | 0.0% |
| Q4 2013 | $823,000 | -32.0% | 709,857 | -1.4% | 0.00% | 0.0% |
| Q3 2013 | $1,210,000 | -14.4% | 720,275 | +1.9% | 0.00% | -50.0% |
| Q2 2013 | $1,414,000 | – | 706,831 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 4,337,858 | $5,032,000 | 0.14% |
| PRICE MICHAEL F | 748,200 | $868,000 | 0.11% |
| ALGERT GLOBAL LLC | 124,891 | $145,000 | 0.04% |
| Rotella Capital Management, Inc. | 13,701 | $16,000 | 0.03% |
| Icahn Capital | 5,904,863 | $6,850,000 | 0.02% |
| Spark Investment Management LLC | 110,100 | $127,000 | 0.02% |
| FCG ADVISORS, LLC | 20,000 | $23,000 | 0.02% |
| BRANDES INVESTMENT PARTNERS, LP | 1,023,893 | $1,188,000 | 0.02% |
| GLOBEFLEX CAPITAL L P | 101,454 | $117,000 | 0.01% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 129,089 | $149,000 | 0.01% |